SNPS Investors, You Need to Know These Facts Today.

By Naomi Wentworth • Wednesday, September 06 10:58 • Permanent Link

Synopsys logged a 0.2% change during today's morning session, and is now trading at a price of $467.58 per share. The S&P 500 index moved -1.0%. SNPS's trading volume is 218,904 compared to the stock's average volume of 873,045.

Synopsys trades -3.52% away from its average analyst target price of $484.64 per share. The 14 analysts following the stock have set target prices ranging from $420.0 to $515.0, and on average have given Synopsys a rating of buy.

Anyone interested in buying SNPS should be aware of the facts below:

Synopsys's current price is 559.4% above its Graham number of $70.91, which implies that at its current valuation it does not offer a margin of safety
Synopsys has moved 41.0% over the last year, and the S&P 500 logged a change of 13.0%
Based on its trailing earnings per share of 6.68, Synopsys has a trailing 12 month Price to Earnings (P/E) ratio of 70.0 while the S&P 500 average is 15.97
SNPS has a forward P/E ratio of 36.8 based on its forward 12 month price to earnings (EPS) of $12.7 per share
The company has a price to earnings growth (PEG) ratio of 2.46 — a number near or below 1 signifying that Synopsys is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 11.94 compared to its sector average of 6.23
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits.
Based in Mountain View, the company has 19,000 full time employees and a market cap of $71.13 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.